Condition
Colorectal Cancer Recurrent clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Colorectal Cancer Recurrent clinical trials that are recruiting, at sites in 4 countries (most in China (4), United States (2), Spain (1)). By phase: Phase 3 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Colorectal Cancer Recurrent clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Predicting who will benefit from adjuvant chemotherapy in stage II–III colorectal cancer using tumor splicing patterns | — | Duarte, California | Recruiting | Nov 10, 2025 |
| Intravenous HNF4α srRNA (CD-GA-102) for unresectable or metastatic colorectal cancer | Early Phase 1 | Shanghai, None Selected | Recruiting | Jul 3, 2025 |
| Comparing two treatments for advanced colorectal cancer | Phase 3 | Hangzhou, Zhejiang | Recruiting | May 28, 2025 |
| Predicting recurrence of high-risk colorectal polyps using microbiota and metabolites | — | Beijing | Recruiting | May 4, 2025 |
| Using Ga-68-FAPI-46 PET scans to detect colorectal cancer recurrence | — | Taipei, Beitou | Recruiting | Jan 10, 2025 |
| Predicting recurrence in stage II/III colorectal cancer after chemotherapy | — | Monrovia, California and 3 other locations | Recruiting | Mar 18, 2024 |
All recruiting trials (6)
-
Predicting who will benefit from adjuvant chemotherapy in stage II–III colorectal cancer using tumor splicing patterns
This project tests whether a tumor splicing signature from surgical tissue can help predict which people with stage II–III colorectal cancer will benefit from adjuvant chemotherapy.
-
Intravenous HNF4α srRNA (CD-GA-102) for unresectable or metastatic colorectal cancer
This trial will try IV CD-GA-102 (HNF4α srRNA) alone or with other cancer medicines to see if it is safe and can help adults with unresectable or metastatic colorectal cancer who have progressed on or cannot tolerate standard treatments.
-
Comparing two treatments for advanced colorectal cancer
This study is testing whether a combination of two cancer treatments works better than another combination for people with advanced colorectal cancer that hasn’t responded to other therapies.
-
Predicting recurrence of high-risk colorectal polyps using microbiota and metabolites
This study is trying to see if the bacteria and substances in the gut can help predict if high-risk colorectal polyps will come back after they've been removed.
-
Using Ga-68-FAPI-46 PET scans to detect colorectal cancer recurrence
This study is testing if a new type of PET scan can better detect colorectal cancer recurrence in patients with high CEA levels after surgery compared to the standard scan.
-
Predicting recurrence in stage II/III colorectal cancer after chemotherapy
This study is trying to create a test that can help predict if people with stage II/III colorectal cancer will have their cancer come back after chemotherapy.
Related topics
Quick answers
How many Colorectal Cancer Recurrent clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (4 trials), United States (2 trials), Spain (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.